Elanco Animal Health Incorporated (ELAN) key performance indicators and operating metrics (15 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization Margin | 24.50 percent | FY2026-Q1 |
| Adjusted Earnings per Share (Diluted) | 0.40 USD_per_share | FY2026-Q1 |
| Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization | 334M | FY2026-Q1 |
| Farm Animal Revenue | 642M | FY2026-Q1 |
| Pet Health Revenue | 710M | FY2026-Q1 |
| Adjusted Gross Profit Margin | 57.00 percent | FY2026-Q1 |
| Cattle Revenue | 316M | FY2026-Q1 |
| Contract Manufacturing and Other Revenue | 19M | FY2026-Q1 |
| Poultry Revenue | 230M | FY2026-Q1 |
| Swine Revenue | 96M | FY2026-Q1 |
| Adjusted Net Income | 64M | FY2025-Q4 |
| Net Leverage Ratio (Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization Basis) | 3.70 ratio | FY2025-Q3 |
| Credelio Quattro Dollar Share (United States Veterinary Clinics) | 14.00 percent | FY2025-Q2 |
| Zenrelia Penetration (United States Clinics) | 35.00 percent | FY2025-Q1 |
Back to ELAN overview · ELAN earnings · ELAN holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.